Pharmaceutical Giants Tackle Patent Law Obviousness in Sanofi-Aventis Deutschland v. Mylan Pharmaceuticals Case

In a recent federal case, Sanofi-Aventis Deutschland GmbH v. Mylan Pharmaceuticals Inc., the issues of subject matter eligibility and obviousness were once again brought to the fore. The case follows on from landmark Supreme Court decisions including Mayo, Myriad, Alice, and most notably, KSR Int’l Co. v. Teleflex Inc. (2007), in which the Court first…

Read More

Supreme Court Ruling Streamlines Patent Challenges, Bolsters Competition in Pharmaceutical Industry

On May 18, 2023, the Supreme Court upheld a decision on streamlining patent challenges by rivals against drug makers. This outcome was brought into effect through the ruling in the case, Amgen Inc. v. Sanofi, as it confirms the Federal Circuit’s (CAFC) decision on enablement. This significant CAFC decision makes it more challenging for pharmaceutical…

Read More

Cannabis Industry Adapts to Unique Intellectual Property Challenges with Employment Agreements

The cannabis industry, already rife with its own set of unique legal hurdles, is now tackling the challenge of protecting intellectual property—a particularly vulnerable area for any young, rapidly growing sector. Any successful business strategy needs a mandatory need for comprehensive employment agreements as part of its operational bedrock. As noted in this comprehensive, rigorous…

Read More

Understanding Hatch-Waxman and BPCIA: Proficiency Series for Legal and Life Sciences Professionals

A webinar series, titled “3rd Annual Passport to Proficiency on the Essentials of Hatch-Waxman and BPCIA,” is slated to hold from October 10th through 26th, starting daily at 1:00 pm EST. This digital event comes with an especial interest for legal professionals and business executives involved in the biopharmaceutical industry as it aims to provide…

Read More

Intellectual Property Rights Dilemma: Zotz’s International Expansion Hindered by Patent Issues

Recent events have spotlighted a growing concern in the international business and legal sectors related to intellectual property rights and patent filing procedures. A specific highly-publicized case revolves around a company named Zotz, which designs and manufactures toys for children. As described in a recent article on JD Supra, Zotz decided to expand its operations…

Read More

PTAB Review September 2023: Analysis of Sanctions Practice and Recent Federal Circuit Decisions

The September 2023 PTAB Review begins with an analysis of recent trends in sanctions practice at the Patent Trial and Appeal Board (PTAB). Legal professionals working at corporations and law firms may find this analysis of particular relevance, as the enforcement and interpretation of these sanctions have noticeable implications on the daily proceedings of the…

Read More

CRISPR Gene Editing Patent Dispute Continues Between Broad Institute and CVC

In a recent legal update, the Broad Institute, jointly with Harvard University and MIT, (referred to as “Broad”) handed in their reply brief relating to the cross-appeal of Interference No. 106,115. This marks another chapter in the ongoing legal framework surrounding CRISPR-mediated gene editing patent rights, with Broad contesting a decision from the Patent Trial…

Read More

Masterclass on Navigating AI Patenting at EPO and USPTO: Bridging the Gap in Intellectual Property Law

In a rapidly digitizing world, the intersection of artificial intelligence and patent law is increasingly crucial. Recognizing this, Partners Martin Zoltick (“Marty”) and Brian Rosenbloom will be sharing their insights and experiences in a masterclass, titled “Practical Masterclass in Patenting AI at the EPO and USPTO“. The webinar is co-organized in conjunction with Haseltine Lake…

Read More